How is pulmonary tuberculosis diagnosed?

Tuberculosis (TB) significantly impacts daily life. Patients may experience various symptoms, and more severe manifestations can substantially impair quality of life. Therefore, timely evaluation of suspicious symptoms is crucial—pulmonary TB patients often present with characteristic clinical features. So, how is pulmonary tuberculosis diagnosed?

How Is Pulmonary Tuberculosis Diagnosed?

Diagnosis of pulmonary tuberculosis primarily relies on chest imaging studies, sputum smear microscopy, and Mycobacterium tuberculosis culture; in some cases, fiberoptic bronchoscopy is also employed. Chest imaging—particularly high-resolution computed tomography (CT)—plays a pivotal role in diagnosis, enabling detection of lesions in concealed areas and aiding differentiation of solitary pulmonary nodules. CT provides superior sensitivity over conventional chest X-ray in visualizing mediastinal and hilar lymphadenopathy, pulmonary cavitation, calcifications, air bronchograms, and bronchiectasis. Sputum smear microscopy and M. tuberculosis culture remain the most specific diagnostic methods. Given the rarity of nontuberculous mycobacteria in China, a positive acid-fast bacillus (AFB) smear is generally sufficient to establish a diagnosis of pulmonary TB. When diagnosis remains uncertain despite initial testing, bronchoscopic biopsy of bronchial or pulmonary lesions can facilitate definitive diagnosis and differential diagnosis.

Tuberculosis is a chronic infectious disease caused by Mycobacterium tuberculosis, capable of affecting multiple organ systems; pulmonary involvement is the most common presentation. Treatment of pulmonary TB encompasses antitubercular drug therapy, symptomatic management, and, in select cases, surgical intervention—with antimicrobial chemotherapy serving as the cornerstone for both treatment and prevention of transmission. Antitubercular regimens are tailored based on whether the patient is newly diagnosed (drug-naïve) or previously treated (retreatment), and whether drug resistance is present. For extrapulmonary or disseminated TB involving multiple sites, therapeutic strategies vary according to the anatomical distribution and extent of disease. Additionally, some pulmonary TB patients experience recurrent hemoptysis; in such cases, surgical resection of the affected lung segment may be considered following initiation of appropriate antitubercular therapy.

Patients are advised to maintain healthy lifestyle habits, follow a balanced diet, avoid spicy and irritating foods, and engage in moderate physical activity to bolster immune function. We hope this information proves helpful.